Bacteria have developed resistance against every antibiotic at a rate that is alarming considering the timescale at which new antibiotics are developed. Thus, there is a critical need to use antibiotics more effectively, extend the shelf life of existing antibiotics and minimize their side effects. This requires understanding the mechanisms underlying bacterial drug responses. Past studies have focused on survival in the presence of antibiotics by individual cells, as genetic mutants or persisters. Also important, however, is the fact that a population of bacterial cells can collectively survive antibiotic treatments lethal to individual cells. This tolerance can arise by diverse mechanisms, including resistance-conferring enzyme production, titration-mediated bistable growth inhibition, swarming and interpopulation interactions. These strategies can enable rapid population recovery after antibiotic treatment and provide a time window during which otherwise susceptible bacteria can acquire inheritable genetic resistance. Here, we emphasize the potential for targeting collective antibiotic tolerance behaviors as an antibacterial treatment strategy.
A ntibiotic-resistant bacteria have emerged as a global crisis, resulting in increased morbidity rates, mortality rates and healthcare costs. The time interval between the introduction of a new antibiotic and the emergence of resistance has rapidly decreased since the 1930s, largely as a result of antibiotic overuse and misuse 1 . Concurrently, a lack of financial incentive has led pharmaceutical companies to decrease antibiotic research and development 2 . Given the diminishing antibiotic pipeline, it is critical to develop a detailed understanding of how bacteria survive antibiotic treatment, as a means to uncover new treatment strategies and make it possible to use existing antibiotics more effectively 3 . Bacteria can survive antibiotics via many different mechanisms (Fig. 1a) . Genetic resistance can arise from de novo mutations or horizontal gene transfer 4 . Expression of resistance proteins can allow individual bacteria to survive antibiotic treatment by deactivating the antibiotic, altering the antibiotic's target or preventing its intracellular accumulation 1, 4 . Bacteria can also exhibit phenotypic tolerance, whereby they survive antibiotic treatment without acquiring new mutations 5 . For example, a predominantly sensitive population often has a very small fraction of non-or slow-growing bacteria (persisters). These persisters may emerge stochastically, in response to stress, or as a result of errors in replication and cell metabolism 6, 7 . They are genetically identical to susceptible cells but are tolerant to antibiotics 7, 8 . In the absence of antibiotics, persisters can switch back to the growing state, leading to population recovery. As a result, persisters can cause post-treatment relapses and enable development of genetic resistance 8 . Unlike genetic resistance, persistence is non-inheritable, though the frequency of persisters in a population can be genetically determined 8, 9 . In contrast, a population at a sufficiently high density can survive an antibiotic dose that is lethal to a low-density population (Fig. 1b,c) . Such collective antibiotic tolerance (CAT) can arise from diverse mechanisms, including collective synthesis of resistanceconferring enzymes, antibiotic titration, and social interactions within and between populations [10] [11] [12] . CAT enables a population to recover faster than does the presence of persisters, and it provides a time window for otherwise susceptible bacteria to acquire genetic resistance (Box 1, Fig. 2 ). Here, we review mechanisms underlying CAT, their characteristic dynamics, and potential strategies to inhibit or exploit these mechanisms for antibacterial treatment.
Mechanisms underlying CAT
Antibiotic-mediated altruistic death. Genetic antibiotic resistance arises from the expression of resistance-conferring proteins, which often degrade or modify the antibiotic 4 . However, expression of the resistance protein may be insufficient to provide single-cell-level protection, depending on the antibiotic concentration. If so, the fate of a bacterial population will depend on its density (Fig. 3a) : population survival is determined by the relative rates of antibioticmediated killing and population-mediated antibiotic degradation. The population will initially decline owing to antibiotic-mediated killing of some bacteria. This death is altruistic because the subsequent release of resistance proteins from the dead cells will benefit the surviving cells by contributing to antibiotic degradation 13, 14 .
If the initial population density is too low, the population will be eradicated before the antibiotic is degraded to a sublethal level. Conversely, if the initial population density is sufficiently high, the total resistance protein released will be enough to clear the antibiotic before complete eradication of the population, allowing the survivors to repopulate. The interplay between cell growth, antibioticmediated killing and antibiotic degradation by the resistance protein from cells (live or dead) will result in CAT. Indeed, smaller inocula of pathogens expressing β-lactamases (Bla) are more susceptible to β-lactams than larger inocula 15 . Such CAT often arises from constitutive expression of Bla and other resistance proteins 16 . Alternatively, many pathogens' Bla expression is upregulated through the induction of ampC in the presence of β-lactam antibiotics 16 . Partial population death is a natural consequence of bactericidal antibiotic action. In other contexts, antibiotic-mediated death is genetically programmed 13 . For example, some antibiotics affect bacterial death by interfering with toxin-antitoxin systems 17 . The mazEF system can result in programmed cell death (PCD) when an antibiotic, such as chloramphenicol, inhibits the transcription and 19 . During a stress response, PCD can benefit survivors by directly or indirectly relieving stress 13, 14 . When this occurs, the use of antibiotics can promote the survival of a pathogen and aggravate its virulence. For instance, antibiotics induce PCD in Shiga toxin (Stx)-producing Escherichia coli (STEC) O157:H7. Encoded in a bacteriophage 20 , Stx is assembled and released upon cell lysis. Stx kills nearby eukaryotic predators, thereby enabling STEC growth and survival 21 . Death here is altruistic and required for the release of Stx. The population must be large enough to afford the cost of lysing the bacteria necessary to release sufficient Stx for survival.
Quorum sensing and biofilm formation. If a resistance protein's production is costly, it may be advantageous to delay synthesis until the cell density is high enough so that the overall benefit of the protein to the population outweighs its production cost. This delay can be realized by quorum sensing (QS), which enables bacteria to coordinate gene expression in a density-dependent manner 22, 23 . In QS, individual cells produce a signaling molecule that increases in extracellular concentration with cell density. By sensing the signal concentration, bacteria can coordinate gene expression according to their density 22 . Using a synthetic gene circuit, QS has been demonstrated to represent an optimal strategy for controlling the expression of a costly protein that benefits the entire population 24 . QS could control the expression of resistance-conferring enzymes (Fig. 3b) . In Providencia stuartii, a Gram-negative pathogen that causes urinary catheter infections, QS controls the expression of an acetyltransferase that inactivates aminoglycoside antibiotics 25, 26 . Low-density populations express minimal levels of acetyltransferase, rendering them sensitive to aminoglycosides; high cell density triggers acetyltransferase expression, yielding CAT.
QS can also contribute to CAT by modulating biofilm formation, which enhances antibiotic tolerance 27 . Although the specifics of biofilm formation vary by species, the general steps are similar 23, 28 . Planktonic bacteria first attach to a surface at a low density and begin to form microcolonies, while producing basal levels of QS signals. Once the population reaches a sufficiently high density, the accumulated QS signals activate genes involved in biofilm formation 22 . Depending on the antibiotic and bacterial species, the surface layer of biofilms may serve as a protective barrier for resident bacteria by reducing the penetration rate of some antibiotics 29, 30 . Moreover, some antibiotics, such as piperacillin or ampicillin, can induce antibiotic-deactivating enzymes in biofilms, which can further reduce antibiotic penetration and the killing of biofilm-residing bacteria 31, 32 . Biofilms also have limited nutrients at their core, which diminishes internal cell growth. These slow-growing cells tend to be less sensitive to certain antibiotics 33 .
Bistable inhibition of the replication machinery. When bacterial populations produce a resistance-conferring protein, density dependence may be intuitive: increasing cell density increases total protein production, thus increasing the likelihood that a population will survive treatment 34 . However, CAT has also been observed in response to antibiotics that inhibit ribosome activity and protein synthesis (for example, gentamicin) without requiring the production of degrading enzymes 35 .
A previous study has established a mechanism for CAT in the absence of active antibiotic degradation: intrapopulation antibiotic titration coupled with bistable ribosome inhibition 10 ( Fig. 3c) . In each cell, ribosome synthesis is controlled by positive feedback: ribosomes translate mRNA into proteins, including ribosome components, resulting in ribosome synthesis 36 . This feedback can be inhibited by intracellular antibiotic, resulting in a bistable response 37 . Within a population, the extracellular antibiotic is allocated to individual cells according to the import and export rates across the when a population at a sufficiently high density can survive an antibiotic dose that would be lethal to a low-density population. (c) Initial cell density determines the outcome for a population treated with an antibiotic. For each antibiotic concentration, there is a critical initial density above which the population will recover; below this, the population will die.
Box 1 | recovery time from an antibiotic depends on survival mode
The mechanism by which bacteria survive antibiotic treatment can significantly influence the speed of their recovery. Here, we use previously published models to compare the recoveries of populations dependent on different forms of CAT or persistence 9, 10, 24, 64 . Figure 2a shows that the three CAT populations recover significantly faster than the persisterdependent population. The recovery times decrease as the initial population density increases (Fig. 2b) . Populations surviving by enzyme-dependent CAT actively degrade antibiotic; thus, the antibiotic concentration is quickly reduced to subinhibitory levels, enabling population recovery. In the case of bistable ribosome inhibition, at high cell densities, the intracellular antibiotic concentration is insufficient to overcome the positive feedback in ribosome synthesis, again leading to rapid recovery. In contrast, recovery via persisters requires a relatively long time owing to its dependence on the slow, intrinsic removal of the antibiotic and to the low frequency of persister formation. cell membrane. When import is faster than export, the intracellular antibiotic will be higher than the extracellular concentration, and it will decrease slightly with increasing cell density. This decrease is amplified by ribosomal positive feedback, leading to bistable growth inhibition: at high cell densities, the average intracellular antibiotic concentration is relatively low (below minimum inhibitory concentrations), and positive feedback overcomes antibiotic inhibition and enables population survival. Modeling suggests that density dependence can be modulated by altering various processes, such as drug uptake and binding. However, the critical condition required for CAT in this scenario is the rapid degradation of ribosomes, which can be triggered by antibiotics that target ribosomal components. These antibiotics induce heat-shock response 38 , which leads to upregulation of proteases and faster degradation of ribosomal components 39 . If the ribosome degradation rate remains slow, as with chloramphenicol treatment, the population fate is density independent: populations either grow (low antibiotic concentrations) or die (high antibiotic concentrations). When coupled with direct induction of heat shock, however, these antibiotics can also cause bistable inhibition of population growth, leading to CAT.
Mixed strategies. In nature, CAT often arises from traits that are controlled by combinations of the mechanisms discussed above. For example, when PCD is coupled with densitydependent gene expression in Staphylococcus aureus, lysis is tightly controlled and can result in CAT through biofilm formation. CidA and LrgA expression turns lysis on and off, respectively, at specified stages of cell growth 40 . Lysis releases genomic DNA, resulting in enhanced biofilm formation 41, 42 . These genes have been linked to regulation of antibiotic tolerance: mutations disrupting CidA or LrgA enhance or reduce population survival, respectively 40, 43 . Another strategy to survive antibiotic treatment involves a combination of phenotypically shifting from a 'swimming' state (planktonic growth) to a 'swarming' state (surface growth), QS, and altruistic death (Fig. 3d) . Swarming is flagella-driven group migration of bacteria over a semisolid surface and happens exclusively at the leading edge of a population 44, 45 . Although the underlying mechanisms are species dependent and not fully elucidated, some swarming species have been observed to rely on QS to upregulate the production of biosurfactants, such as rhamnolipids, which are necessary for reducing surface tension 44 . Swarmers exhibit increased tolerance of a variety of antibiotics, including aminoglycosides and fluoroquinolones 45, 46 . Altruistic death may contribute to this survival advantage. It is speculated that cells dying from prolonged direct contact with the antibiotic form a protective platform that prevents other swarmers from coming into direct contact with it 45 . Thus, the population has to have a high enough density to upregulate QS-mediated swarming genes 45 and be able to afford the cost of losing individuals that are directly exposed to the antibiotic. Although swarming and biofilm formation involve similar mechanisms, such as altruistic death and QS, the two states are inversely regulated 47, 48 . As a result, biofilms contain a population of sessile cells, whereas swarms disperse a population of active cells 48 . The mechanisms underlying swarming-mediated motility and density-dependent survival appear to vary between species; QS has been implicated in these mechanisms in Pseudomonas aeruginosa 44 but not in Salmonella enterica serovar Typhimurium 45 . Other studies have examined the impact of biofilm creation 45 and increased efflux pump expression 49 . Swarming motility has been observed to strongly correlate with the expression of the pmrHFIJKLM operon 46 . This operon encodes the lipid A portion of LPS, which reduces the binding strength of various antimicrobial peptides 50 . A previous study shows pmrK expression is upregulated in conditions that promote swarming. Expression decreases as cells de-differentiate from the swarming phenotype, and knockout results in the loss of swarming ability 46 .
Social interactions.
In a mixed population, CAT can be facilitated by 'charitable' actions, wherein one subpopulation produces a product that helps another subpopulation, without receiving any benefit from the latter (Fig. 3e) . For example, a recent study demonstrated how a population of drug-sensitive E. coli can tolerate an antibiotic with the aid of a few highly resistant population members 51 . In the absence of antibiotic, the entire population produces indole, a signaling molecule generated by growing bacteria. In the presence of an antibiotic, however, only a subpopulation with mutated efflux pumps has the resistance necessary to continue producing large amounts of indole. The released indole upregulates efflux pump expression and oxidative-stress mechanisms, thus enabling the entire population to tolerate the antibiotic. This survival tactic will fail if the fraction of mutant indole producers is too small to support a large population of sensitive cells or if the metabolic cost of indole production is too high.
CAT can also arise from mutualistic interactions, whereby two or more bacterial populations depend on one another to survive. For instance, an engineered system can demonstrate how two populations can collaborate to survive different antibiotics 12 . Each engineered population produced the QS signal molecule needed by the other to upregulate the production of a resistance protein. Increasing either population's initial density increased QS signal accumulation, resulting in higher final densities after antibiotic treatment.
Similarly, multispecies swarms can arise due to the communal nature of QS signals. For example, Serratia ficaria do not produce biosurfactants, but they do produce QS signals necessary for Serratia liquefaciens QS-deficient mutants to upregulate their own biosurfactant production. Once sufficient signaling molecules accumulate, S. liquefaciens' biosurfactant production facilitates the swarming 52 and, presumably, the CAT of both populations. Another example of mutualism-mediated CAT can be found in multispecies biofilms 53 . For example, species can work together to decrease antibiotic penetration of biofilms. Burkhodia cepacia and P. aeruginosa, both associated with cystic fibrosis, produce polysaccharides that interact to increase biofilm viscosity and decrease antibiotic activity 54 .
implications for antimicrobial treatment strategies
The diverse mechanisms underlying CAT have implications for the development of new treatment strategies. In particular, different mechanisms can lead to unique population and evolutionary dynamics that can be exploited for better treatment efficacy or can serve as cautionary tales against simplistic treatment strategies.
Timing in antibiotic dosing.
A common property of CAT mechanisms is that a bacterial population is most vulnerable at low densities. This suggests the possibility of inhibiting bacterial growth by controlling the timing of antibiotic doses. One method would be to detect and treat infections at earlier stages of development, when insufficient bacteria are present to generate CAT (Fig. 4a) . A mouse study on the treatment of STEC infections showed that early treatment (1-3 days after infection) with a lysis-inducing antibiotic resulted in zero mortality, while late treatment (3-5 days after infection) resulted in 95% mortality 55 . The improved outcome with early treatment may have resulted from suppression of bacterial growth or virulence factor production. Targeting early-stage infections is also effective in treating biofilms; studies have demonstrated that immature biofilms are more susceptible to antibiotic treatment 56, 57 . Timing control is intrinsic in the design of periodic antibiotic dosing protocols, which can be determined by the dynamic response of a population exhibiting CAT. A previous study demonstrated that different periodic dosing frequencies have drastically different outcomes when treating a population capable of generating CAT due to bistable ribosome inhibition 10 . When antibiotic doses were delivered at high frequency, populations had insufficient time to recover. Conversely, when doses were delivered at low frequency, the antibiotic eradicated the population to such an extent that it could not recover. For intermediate frequencies, however, treatment was ineffective; populations recovered between doses. Furthermore, the frequency range over which populations are able to survive can be modulated by changing the fraction of each period spent at a high antibiotic concentration. In general, the optimal dosing protocol is likely to depend on the specific types of mechanisms by which CAT arises, making the investigation of these mechanisms a potentially fruitful direction for quantitative biology research.
Molecular interventions to disrupt CAT. Different mechanisms underlying CAT also suggest potential targets for molecular-level intervention (Fig. 4b) . CAT facilitated by enzyme expression can be reduced by inhibiting either the production or the action of the enzyme. These strategies are often adopted for treating bacteria that produce Bla. Weak inducers of AmpC Bla production, such as cefepimes and piperacillin, have been shown to have lower minimal inhibitory concentrations (MICs) when treating inducible pathogens 58 . Alternatively, a Bla inhibitor, such as clavulanic acid, sulbactam or tazobactam, is frequently used in conjunction with a β-lactam antibiotic to treat Bla-producing bacteria 59 . It should be noted that some bacteria have already evolved mechanisms of resistance to Bla inhibitors 60 . This strategy can also be applied to target CAT resulting from PCD. Studies have begun to screen antimicrobial peptides that activate killing by triggering bacterial toxin-antitoxin systems 61, 62 . For some pathogens, however, activation of PCD alone may be undesirable as it can enhance bacterial survival and virulence. Instead, PCD inhibition can reduce virulence by suppressing the release of effectors that promote bacterial survival or virulence. For example, in Streptococcus pneumoniae, release of a virulence factor to extracellular space is mediated by autolysis of a subpopulation of cells 63 , which in turn can benefit survivors. Serum from mice immunized with autolysin inhibited autolysis and reduced bacterial virulence 63 . It will be interesting to examine how such strategies will affect overall bacterial survival. As demonstrated using synthetic gene circuits 64 , reduced lysis can paradoxically lead to overall worse bacterial survival.
Similar strategies that inhibit either the production or the action of an enzyme have been applied to target QS pathogens. Targeting QS is appealing as it can reduce virulence without directly targeting the immediate survival of cells. For example, azithromycin has been shown to inhibit QS signaling, leading to inhibition of biofilm formation and virulence in P. aeruginosa 65, 66 . Likewise, molecules such as the enzyme AiiA, which hydrolyzes QS signal molecules 67 , and synthetic molecules that prevent AHL receptor activation 68 can also block QS signaling and cause decreased virulence and increased susceptibility to antibiotic treatment in QS pathogens 69 . Drugs that target the function of QS-mediated proteins have also been studied. Oseltamivir is a drug originally developed to inhibit viral production of neuraminidase. As neuraminidase is also a QS-mediated enzyme essential for P. aeruginosa's initial colonization process and sub sequent biofilm formation, oseltamivir has been tested for its ability to inhibit biofilm formation. Indeed, a dose-dependent decrease in biofilm formation was observed when oseltamivir was applied 70 . Rapid ribosome turnover is a prerequisite to generating CAT against antibiotics that target ribosomes 10 . As the rate of ribosome turnover increases, the range of antibiotic concentrations over which CAT occurs shrinks and shifts toward lower values. To reduce or eliminate CAT, future drug development could focus on alternative avenues to disrupt ribosome efficacy, such as interfering with subunit assembly 71 . Another means to eliminate CAT might be to target pathways involved in the stringent response, a process found in many bacterial species in which, in response to various stresses, the bacteria reduce rRNA transcription and ribosome synthesis while upregulating amino acid synthesis 72 . These metabolic shifts can promote bacterial survival and virulence 73 . Inhibition of such metabolic shifts could prevent CAT at high population densities. These pathways may thus represent potential targets for new drugs 74 . A prior study observed that a fundamental requirement for swarming is the production of extracellular surfactants, particularly lipopolysaccharides (LPS), which lubricate cells' local environment so they can 'slide' past each other 46 . Therefore, the increased antibiotic tolerance exhibited by swarmers could be avoided by inhibiting LPS production 75 . Previous studies have shown that LPS inhibition by antimicrobial peptides results in the loss of swarming motility 50 . A caveat is that inhibiting swarming motility could lead to increased biofilm formation 76 , as these phenotypes are often linked. Finally, mixed populations can be inhibited by targeting the keystone members. In the case of charitable interactions, treatments should target the subpopulation producing the resistance protein that protects producers and non-producers alike. For instance, penicillin treatment of tonsillitis is often ineffective due to mixed populations of Bla-producing pathogens that protect streptococci. However, the infections were effectively treated upon the introduction of a Bla inhibitor, clavulanic acid 77 . In a mutual relationship, such as in the aforementioned synthetic system 12 , survival depends on both subpopulations being present. For such systems, a viable treatment strategy could be to disable one subpopulation such that all participating subpopulations became more susceptible to treatment. To this end, clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems could represent an ideal antimicrobial strategy to directly target the specific subpopulations that promote CAT. This genome-editing tool utilizes targeted guide RNA sequences that can be designed to recognize desired bacterial DNA and induce nucleic acid breaks, which can disrupt gene function in the target. Indeed, recent studies demonstrate the ability to customize antimicrobial treatments through the targeted inactivation or killing of specific bacteria within a population through CRISPR delivery 78, 79 . Treatment considerations. Depending on the underlying mechanisms, complex treatment responses could arise from populations capable of CAT. One counterintuitive response is the Eagle effect, a phenomenon wherein increasing antibiotic concentration promotes bacterial recovery 80 .
Whether and to what extent the Eagle effect happens in the clinical setting remains to be tested; however, the Eagle effect has been observed to result from PCD-mediated tolerance in vitro 64 . Another example is the counterintuitive effect of inhibiting different aspects of QS. Inhibiting QS signal synthesis effectively increases the cell density threshold required to trigger downstream gene expression, such as virulence factor production 81 . However, QS inhibition also alleviates the metabolic burden placed on each cell, resulting in faster growth 24 . Despite this caveat, the overall outcome of QS signaling inhibition ultimately depends on bacterial survival and virulence development. The treatment would likely be considered successful if the target bacteria were rendered nonpathogenic 82 . While QS inhibition can attenuate virulence in the short term, it can promote the selection of more virulent pathogens in the long term 83 . For example, long-term inhibition of QS signaling in P. aeruginosa by azithromycin can select for more cooperative and virulent individuals 66, 83 . Azithromycin inhibits general protein synthesis; however, it has been shown that QS-regulated genes are among the most severely inhibited by this drug 84 . Over an 11-day course of azithromycin in intubated patients colonized by P. aeruginosa, a slight decrease in the frequency of QS-deficient mutants was observed, whereas this frequency increased approximately twofold in the placebo group 83 . One possible explanation for this counterintuitive response is that, when uninhibited, the cooperative nature of QS is prone to permitting cheaters: cells that do not produce virulence factors exploit the benefit while avoiding the cost of public good (that is, virulence factors) production 85 . Cheaters, therefore, are less virulent but have a fitness advantage. For instance, P. aeruginosa cheaters that are QS deficient as a result of LasR mutations have a growth advantage over wild-type bacteria 66, 86 . When the QS signal is inhibited and no public goods are synthesized, the fitness advantage to the cheaters will be reduced, making it more difficult for them to outcompete cooperators. The negative consequences of direct inhibition of enzyme production may be avoided by inhibiting the enzyme after it is produced 87 . This strategy aims to maintain the cost of enzyme production while eliminating its benefits, leaving virulent bacteria at a metabolic disadvantage and more vulnerable to treatment. This method may also reduce the selective pressure induced by antibiotic treatment, slowing pathogens' adaptive response.
Although resistance has been well studied, prediction of its long-term consequences for bacterial dynamics has proved elusive. Bacteria have already developed strategies to survive QS inhibition 83 and combination treatments involving Bla inhibitors 60 and are likely to develop strategies to survive other inhibition methods. A better understanding of bacterial population and evolutionary dynamics under the influence of different treatment strategies can help us optimize treatment strategy. More quantitative studies are needed to better establish the evolutionary dynamics involved in QS-mediated cooperation and the impact of inhibition on different aspects of QS. For instance, the discussion above considers only QS effectors that are public goods. The evolutionary outcomes can be significantly different if the effectors are private goods, which benefit only the cell that produces them 88 , or species-specific goods, which benefit only a particular population of cells 89 . The same challenge is applicable for the population and evolutionary dynamics of other mechanisms leading to CAT. To this end, the use of well-defined model systems 90 , both natural 10, 88, 91, 92 and engineered 24, 64, 89 , will be valuable for the development of better quantitative understanding of a population's response to antibiotics. This understanding can serve as the critical foundation to design 'evolution-proof ' treatment strategies that select against resistance 
